Fig. 4
From: ZDHHC15 promotes glioma malignancy and acts as a novel prognostic biomarker for patients with glioma
Knockdown of ZDHHC15 inhibits glioma cell proliferation. (A) A CCK-8 assay was used to evaluate the viability of glioma cells after the downregulation of ZDHHC15. (B) Cell cycle-related key proteins of U251 and U87 cells were detected by Western blotting assay after transfection of ZDHHC15 siRNA. (C) The effect of ZDHHC15 knockdown on cell migration of U251 and U87 cells was examined by Transwell assay. (D) Cell migration-related key proteins of U251 and U87 cells were detected by Western blotting assay after transfection of the ZDHHC15 siRNA. Student’s t-test. *P < 0.05, **P < 0.01, ****P < 0.0001. Scale bars, 100 μm